Inflammatory Myopathy
📧 Sign up to get email alerts when something new happens for Inflammatory Myopathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-01Clinical Trial Update: Virtual Reality and Robotics in Inflammatory Myopathy Rehabilitation [NA]
This clinical trial update reports the completion of a study evaluating virtual reality and robotics-enabled rehabilitation for inflammatory…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Natural History of Inflammatory Muscle Diseases
Observational clinical trial studying the natural history of inflammatory muscle diseases, sponsored by NIAMS, currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases [Phase 1]
Exploratory Phase 1 clinical trial evaluating YTS109 Cell for relapsed/refractory autoimmune diseases, including systemic lupus erythematosu…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Exploratory Clinical Study on YTS109 Cell Therapy for Autoimmune Diseases [Phase 1]
A Phase 1 exploratory study evaluating the safety and feasibility of YTS109 cell therapy for multiple autoimmune diseases, currently recruit…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune Diseases [Phase 1]
Phase 1 trial update on YTS109 cell therapy for relapsed/refractory autoimmune diseases, currently recruiting across multiple indications.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases [Phase 1]
Phase 1 clinical study of YTS109 cell therapy for refractory autoimmune diseases is currently recruiting. The trial will evaluate safety and…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: A Clinical Study of TI-0032-III Injection in Patients With Relapsed and Refractory Autoimmune Diseases [Phase 1]
A Phase 1 clinical trial of TI-0032-III Injection for relapsed and refractory autoimmune diseases is currently recruiting, encompassing seve…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: UCAR T-cell Therapy Targeting CD19/ BCMA(QT-019C) in Patients With Relapse/ Refractory Autoimmune Diseases [EARLY_Phase 1]
An early-phase (Phase 1) clinical trial evaluating QT-019C UCAR T-cell therapy targeting CD19/BCMA for relapse or refractory autoimmune dise…
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: CAR T-cell Therapy Targeting CD19 and BCMA in Patients With Relapse/Refractory Autoimmune Diseases [Phase 1]
Phase 1 clinical trial update assessing a dual CD19/BCMA-targeted CAR T-cell therapy for relapse/refractory autoimmune diseases, currently r…
-
CLINICAL_TRIALS research · 2025-07-14Clinical Trial Update: A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases [Phase 1]
A Phase 1 clinical trial evaluating YTS109 cell therapy for relapsed/refractory autoimmune diseases is currently recruiting. The study cover…
-
CLINICAL_TRIALS research · 2025-05-18Clinical Trial Update: UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune Diseases [Phase 1]
Phase 1 clinical trial update for UCAR T-cell therapy targeting CD19/BCMA in relapse/refractory autoimmune diseases. The study includes seve…
-
CLINICAL_TRIALS research · 2025-04-23Clinical Trial Update: Follow-up of Patients With Inflammatory Myopathies Associated With a Biobank
Clinical trial update noting ongoing recruitment for a biobank–associated study of inflammatory myopathies, including idiopathic inflammator…
-
CLINICAL_TRIALS research · 2024-11-20Clinical Trial Update: Universal CAR-T Cells (BRL-301) in Relapse or Refractory Autoimmune Diseases [NA]
A clinical trial update shows BRL-301 universal CAR-T cells from Bioray Laboratories enrolling (by invitation) for relapse or refractory aut…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: ROLE of PLATELETS in the PATHOPHYSIOLOGY of SYSTEMIC LUPUS
A recruiting clinical study evaluating the role of platelets in the pathophysiology of systemic lupus erythematosus. The study also presents…
-
CLINICAL_TRIALS trial_result · 2024-08-29Clinical Trial Update: An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease [NA]
This clinical trial update reports a study of YTS109 cell injection for recurrent or refractory autoimmune diseases that is currently recrui…
-
CLINICAL_TRIALS research · 2024-05-22Clinical Trial Update: Clinical Database and Biobank of Patients With Inflammatory Myopathies: the MASC Project (Myositis, DNA, Serum, Cells) (MASC)
The MASC Project is a clinical database and biobank collecting DNA, serum, cells, and clinical data from patients with inflammatory myopathi…
-
CLINICAL_TRIALS research · 2024-05-17Clinical Trial Update: The Safety and Efficacy of Anti-CD19 CAR-T Cells in Patients With Relapsed/Refractory Autoimmune Diseases [EARLY_Phase 1]
This clinical trial update covers the safety and potential efficacy of anti-CD19 CAR-T cells for relapsed/refractory autoimmune diseases, wi…
-
CLINICAL_TRIALS trial_result · 2021-05-11Clinical Trial Update: Personalised Prospective Comparison of ARni With ArB in Patients With Natriuretic Peptide eLEvation [Phase 2]
Phase 2 clinical trial comparing ARni with ARB in patients with elevated natriuretic peptide; status currently UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2020-01-23Clinical Trial Update: Low-dose Interleukin-2 in Combination With Standard Therapy on Idiopathic Inflammatory Myopathy [Phase 2]
Phase 2 trial evaluating low-dose interleukin-2 in combination with standard therapy for inflammatory myopathy.
-
CLINICAL_TRIALS trial_result · 2019-08-28Clinical Trial Update: Low-dose Interleukin-2 Treatment on Idiopathic Inflammatory Myopathy [Phase 2]
Phase 2 clinical trial investigating low-dose interleukin-2 for inflammatory myopathy is in progress, with status currently unknown.
-
CLINICAL_TRIALS trial_result · 2019-02-08Clinical Trial Update: Quantitative Muscle Ultrasound as a Marker of Progression in Children With Muscular Diseases
A completed clinical trial from Benha University investigates quantitative muscle ultrasound as a progression marker in children with Duchen…